Bimosiamose

BRAND NAME: none yet GENERIC NAME: Bimosiamose EXPERIMENTAL/INTERNAL COMPANY NAME:

TESTING PHASE II CLINICAL TRIALS CLICK HERE

DRUG USE (P OR PsA)	METHOD OF DELIVERY	DEVELOPING COMPANY/COMPANIES
Plaque psoriasis	Topical cream	Revotar Biopharmaceuticals

Description and Comments

Bimosiamose is a new anti-inflammatory medication. A cream form of bimosiamose is currently being tested as a topical treatment for plaque psoriasis. In early studies bimosiamose appeared to be safe and showed some promising signs of effectiveness. Bimosiamose fights inflammation in a different way than other topical medications for psoriasis.

Other News and Links

Press release: Revotar Biopharmaceuticals Starts Phase II Clinical Trial in Psoriasis with its Bimosiamose 5% Cream